Carmell Therapeutics Corp... (CTCX)
NASDAQ: CTCX
· Real-Time Price · USD
0.20
0.01 (2.77%)
At close: Mar 07, 2025, 3:55 PM
Carmell Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.73 | -2.57 | -2.98 | 3.32 | -1.46 | 160.33 | 87.08 | -15.74 | -7.72 | -134.16 | -91.25 | -202.75 | -547.99 | -0.00 | n/a |
PEG Ratio | 0.06 | 0.11 | 0.02 | -0.02 | 0.00 | -3.59 | -0.74 | 0.31 | -0.00 | 4.12 | -0.73 | -1.19 | 5.48 | n/a | n/a |
PS Ratio | 409.06 | 2.76K | n/a | -11.26 | 18.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -2.07 | -24.79 | -41.17 | 1.70 | 3.21 | 1.30 | 1.29 | -5.19 | 1.25 | 1.25 | 1.29 | 1.27 | 1.28 | 0.00 | n/a |
P/FCF Ratio | 3.42 | -29.87 | -53.25 | -13.35 | -13.27 | -34.57K | -1.17K | -85.16 | -200.47 | -4.31K | -1.27K | -2.68K | -511.84 | n/a | n/a |
P/OCF Ratio | 3.42 | -29.87 | -53.25 | -13.35 | -13.35 | -34.57K | -1.17K | -85.3 | -200.47 | -4.31K | -1.27K | -2.68K | -511.84 | n/a | n/a |
OCF/S Ratio | 119.53 | -92.41 | n/a | 0.84 | -1.35 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.19 | -0.58 | -1.11 | 0.09 | 0.46 | n/a | n/a | -0.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.29 | 0.69 | 0.75 | 1.63 | 0.77 | 0.02 | 0.05 | 0.08 | 0.64 | 0.58 | 1.17 | 2.95 | 9.47 | n/a | n/a |
Current Ratio | 0.31 | 0.71 | 0.75 | 1.63 | 1.03 | 0.02 | 0.05 | 0.08 | 0.64 | 0.58 | 1.17 | 2.95 | 9.47 | n/a | n/a |
Asset Turnover | 0.01 | 0.00 | n/a | -0.06 | 0.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -199.32 | -127.5 | -55.14 | n/a | -12.92 | -4.21 | -2.87 | -8.52 | -0.57 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 0.71 | 2.41 | 3.45 | 0.13 | -0.55 | n/a | n/a | 0.08 | -0.04 | n/a | n/a | n/a | n/a | -0.37 | n/a |
Return on Assets | -1.18 | -0.66 | -0.78 | 0.05 | -0.14 | n/a | n/a | -1.78 | -0.04 | n/a | n/a | n/a | n/a | -0.02 | n/a |
Return on Invested Capital | 0.43 | 2.08 | -12.23 | 0.10 | -0.1 | n/a | n/a | 1.10 | -0.01 | -0.01 | n/a | n/a | n/a | 2.84 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.76 | 0.98 | n/a | 1.00 | 0.59 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -140.28 | -268.23 | n/a | -0.85 | -3.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -140.28 | -268.23 | n/a | -0.64 | -3.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -69.19 | -96.71 | n/a | -0.52 | -1.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -137.85 | -262.74 | n/a | -0.44 | -2.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |